Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening.
Adolescents
Anxiety
Depression
Internalizing symptoms
Juvenile idiopathic arthritis
Mental health
Screening
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
10 Apr 2024
10 Apr 2024
Historique:
received:
29
08
2023
accepted:
19
03
2024
medline:
11
4
2024
pubmed:
11
4
2024
entrez:
10
4
2024
Statut:
epublish
Résumé
Previous studies have shown that growing up with rheumatic conditions can fuel dissatisfaction and psychological distress, which in turn affects disease self-management and treatment adherence. Primary objective of this study was to estimate the prevalence of anxiety and depression symptoms in adolescents and young adults (AYA) with juvenile idiopathic arthritis (JIA) and to identify correlates of conspicuous screening results. Initiated as part of the COACH multicenter observational study, outpatients aged 12 to 21 years participating in the National Pediatric Rheumatological Database (NPRD) were prospectively screened for mental health using the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder Scale-7 (GAD-7). Data from 1,150 adolescents with JIA (mean age 15.6 ± 2.2 years; mean disease duration 7.2 ± 4.9 years, 69% female, 43% oligoarthritis, 26% polyarthritis) were analysed. Overall, 32.7% (n = 316) of AYA showed conspicuous screening results, of whom 30.4% reported clinically relevant suicidal or self-harm thoughts. About 19% of screened patients showed moderate to severe depressive or anxious symptoms. AYA with conspicuous screening results were older (15.8 vs. 15.2 years; p < 0.0001), more often female (81% vs. 64%; p < 0.0001) and more often overweight (25% vs. 17%; p = 0.006). They had higher disease activity (physician global assessment on NRS 0-10; 1.7 vs. 1.2; p < 0.0001), more functional limitations (CHAQ; 0.44 vs. 0.14; <0.0001) and rated their health status worse (NRS 0-10; 3.5 vs. 1.8; p < 0.0001) than AYA with inconspicuous screening results. Females (OR 2.33 [CI 1.53-3.56]; p < 0.0001), older age (OR 1.09 [CI 1.01-1.18]; p = 0.026), patients with more functional limitations (OR 3.36 [CI 1.98-5.72]; p < 0.0001), and patients with worse subjective health status (OR 1.17 [CI 1.07-1.27]; p < 0.0001) were more likely to have a conspicuous screening result. Regular sports participation was associated with a lower likelihood of conspicuous screening result (OR 0.69 [CI 0.49-0.98]; p = 0.039). A large-scale outpatient screening of AYA with JIA in Germany shows a high prevalence of anxiety and depression symptoms. The need for routine screening for early detection of mental health problems became apparent.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies have shown that growing up with rheumatic conditions can fuel dissatisfaction and psychological distress, which in turn affects disease self-management and treatment adherence. Primary objective of this study was to estimate the prevalence of anxiety and depression symptoms in adolescents and young adults (AYA) with juvenile idiopathic arthritis (JIA) and to identify correlates of conspicuous screening results.
METHODS
METHODS
Initiated as part of the COACH multicenter observational study, outpatients aged 12 to 21 years participating in the National Pediatric Rheumatological Database (NPRD) were prospectively screened for mental health using the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder Scale-7 (GAD-7).
RESULTS
RESULTS
Data from 1,150 adolescents with JIA (mean age 15.6 ± 2.2 years; mean disease duration 7.2 ± 4.9 years, 69% female, 43% oligoarthritis, 26% polyarthritis) were analysed. Overall, 32.7% (n = 316) of AYA showed conspicuous screening results, of whom 30.4% reported clinically relevant suicidal or self-harm thoughts. About 19% of screened patients showed moderate to severe depressive or anxious symptoms. AYA with conspicuous screening results were older (15.8 vs. 15.2 years; p < 0.0001), more often female (81% vs. 64%; p < 0.0001) and more often overweight (25% vs. 17%; p = 0.006). They had higher disease activity (physician global assessment on NRS 0-10; 1.7 vs. 1.2; p < 0.0001), more functional limitations (CHAQ; 0.44 vs. 0.14; <0.0001) and rated their health status worse (NRS 0-10; 3.5 vs. 1.8; p < 0.0001) than AYA with inconspicuous screening results. Females (OR 2.33 [CI 1.53-3.56]; p < 0.0001), older age (OR 1.09 [CI 1.01-1.18]; p = 0.026), patients with more functional limitations (OR 3.36 [CI 1.98-5.72]; p < 0.0001), and patients with worse subjective health status (OR 1.17 [CI 1.07-1.27]; p < 0.0001) were more likely to have a conspicuous screening result. Regular sports participation was associated with a lower likelihood of conspicuous screening result (OR 0.69 [CI 0.49-0.98]; p = 0.039).
CONCLUSIONS
CONCLUSIONS
A large-scale outpatient screening of AYA with JIA in Germany shows a high prevalence of anxiety and depression symptoms. The need for routine screening for early detection of mental health problems became apparent.
Identifiants
pubmed: 38600543
doi: 10.1186/s13075-024-03312-x
pii: 10.1186/s13075-024-03312-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
82Informations de copyright
© 2024. The Author(s).
Références
Blakemore SJ, Choudhury S. Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry. 2006;47:296–312.
pubmed: 16492261
doi: 10.1111/j.1469-7610.2006.01611.x
McGrady ME, Hood KK. Depressive symptoms in adolescents with type 1 diabetes: associations with longitudinal outcomes. Diabetes Res Clin Pract. 2010;88:e35–7.
pubmed: 20451278
pmcid: 2916945
doi: 10.1016/j.diabres.2010.03.025
Miller L, Campo JV. Depression in adolescents. N Engl J Med. 2021;385:445–49.
pubmed: 34320289
doi: 10.1056/NEJMra2033475
Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281–95.
pubmed: 34079068
doi: 10.1038/s41380-021-01161-7
Christie D, Viner R. Adolescent development. BMJ. 2005;330:301–4.
pubmed: 15695279
pmcid: 548185
doi: 10.1136/bmj.330.7486.301
Ferro MA, Gorter JW, Boyle MH. Trajectories of depressive symptoms during the transition to young adulthood: the role of chronic illness. J Affect Disord. 2015;174:594–601.
pubmed: 25569612
doi: 10.1016/j.jad.2014.12.014
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
pubmed: 14760812
Petty RE, Laxer RM, Wedderburn LR. Juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, et al. editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2016. pp. 188–204.
doi: 10.1016/B978-0-323-24145-8.00015-6
Fair DC, Rodriguez M, Knight AM, Rubenstein TB. Depression and anxiety in patients with juvenile idiopathic arthritis: current insights and impact on quality of life, a systematic review. Open Access Rheumatol Res Rev. 2019;11:237–52.
Davis AM, GrahamTB, Zhu Y, McPheeters ML. Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus. 2018;27:1532–41.
pubmed: 29954282
pmcid: 6084794
doi: 10.1177/0961203318779710
Szulczewski L, Mullins LL, Bidwell SL, Eddington AR, Pai ALH. Meta-analysis: care giver and youth uncertainty in pediatric chronic illness. J Pediatr Psychol. 2016;42:395–421.
doi: 10.1093/jpepsy/jsw097
Banasiak B, Smolewska E, Zygmunt A, Lipińska J, Biernacka-Zielińska M, Stańczyk J. Coping with anxiety and pain by adolescents with juvenile idiopathic arthritis. Clin Exp Med Lett. 2010;51:1–5.
Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol. 2011;30:1415–20.
pubmed: 21887489
doi: 10.1007/s10067-011-1832-0
Hanns L, Cordingley L, Galloway J, Norton S, Carvalho LA, Christie D, et al. Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis prospective study. Rheumatology. 2018;57:1381–9.
pubmed: 29697850
pmcid: 6055569
doi: 10.1093/rheumatology/key088
Hanns L, Radziszewska A, Suffield L, Josephs F, Chaplin H, Peckham H, et al. Association of anxiety with Pain and disability but not with increased measures of inflammation in adolescent patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2020;72:1266–74.
pubmed: 31199593
doi: 10.1002/acr.24006
Ding T, Hall A, Jacobs K, David J. Psychological functioning of children and adolescents with juvenile idiopathic arthritis is related to physical disability but not to disease status. Rheumatology. 2008;47:660–4.
pubmed: 18356173
doi: 10.1093/rheumatology/ken095
Fair DC, Nocton JJ, Panepinto JA, Yan K, Zhang J, Rodriguez M, et al. Anxiety and depressive symptoms in juvenile idiopathic arthritis correlate with pain and stress using PROMIS measures. J Rheumatol. 2022;49:74–80.
pubmed: 34334368
doi: 10.3899/jrheum.210101
Berthold E, Dahlberg A, Jöud A, Tydén H, Månsson B, Kahn F, et al. The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-swedish juvenile idiopathic arthritis cohort. Pediatr Rheumatol Online J. 2022;20:114.
pubmed: 36494819
pmcid: 9733298
doi: 10.1186/s12969-022-00765-9
Sengler C, Milatz F, Minden K. Mental health in children and adolescents with rheumatic diseases. Screening as an integral part of care. Arthritis und Rheuma. 2022;42:381–88.
Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76:639–46.
pubmed: 27802961
doi: 10.1136/annrheumdis-2016-210112
US Preventive Services Task Force. Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;328:1534–42.
doi: 10.1001/jama.2022.16946
Cameron FJ, Northam EA, Ambler GR, Daneman D. Routine psychological screening in youth with type 1 diabetes and their parents: a notion whose time has come? Diabetes Care. 2007;30:2716–24.
pubmed: 17644619
doi: 10.2337/dc07-0603
Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, et al. International Committee on Mental Health in cystic fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71:26–34.
pubmed: 26452630
doi: 10.1136/thoraxjnl-2015-207488
Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis: long-term outcome in JIA. Arthritis Rheum. 2002;46:2392–401.
pubmed: 12355487
doi: 10.1002/art.10444
Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, et al. Outcome and Trends in treatment of systemic juvenile idiopathic arthritis in the German National Pediatric Rheumatologic Database, 2000–2013. Arthritis Rheumatol. 2016;68:3023–34.
pubmed: 27332999
doi: 10.1002/art.39796
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–97.
pubmed: 16717171
doi: 10.1001/archinte.166.10.1092
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief Depression Severity measure. J Gen Intern Med. 2001;16:606–13.
pubmed: 11556941
pmcid: 1495268
doi: 10.1046/j.1525-1497.2001.016009606.x
Mossman SA, Luft MJ, Schroeder HK, Varney ST, Fleck DE, Barzman DH, et al. The generalized anxiety disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation. Ann Clin Psychiatry. 2017;29:227–34.
pubmed: 29069107
pmcid: 5765270
Nandakumar AL, Vande Voort JL, Nakonezny PA, Orth SS, Romanowicz M, Sonmez AI, et al. Psychometric Properties of the Patient Health Questionnaire-9 modified for major depressive disorder in adolescents. J Child Adolesc Psychopharmacol. 2019;29:34–40.
pubmed: 30388048
pmcid: 6354604
doi: 10.1089/cap.2018.0112
Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31.
pubmed: 26719105
doi: 10.1016/j.genhosppsych.2015.11.005
Tschorn M, Rieckmann N, Arolt V, Beer K, Haverkamp W, Martus P, et al. Erkennungsgüte Dreier Deutschsprachiger Screeninginstrumente für Depression Bei Hospitalisierten Patienten Mit Koronarer Herzerkrankung. Psychiatr Prax. 2019;46:41–8.
pubmed: 28371958
doi: 10.1055/s-0042-123434
Richardson LP, McCauley E, Grossman DC, McCarty CA, Richards J, Russo JE, et al. Evaluation of the Patient Health Questionnaire-9 item for detecting major depression among adolescents. Pediatrics. 2010;126:1117–23.
pubmed: 21041282
doi: 10.1542/peds.2010-0852
Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, et al. Perzentile für den body-mass-index für das Kindes- Und Jugendalter Unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde. 2001;149:807–18.
doi: 10.1007/s001120170107
Foeldvari I, Ruperto N, Dressler F, Hafner R, Kuster RM, Michels H, et al. The German version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ). Clin Exp Rheumatol. 2001;19:S71–5.
pubmed: 11510335
Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, et al. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care Res (Hoboken). 2014;66:1703–9.
pubmed: 24980508
doi: 10.1002/acr.22393
Trincianti C, Van Dijkhuizen EHP, Alongi A, Mazzoni M, Swart JF, Nikishina I, et al. Paediatric Rheumatology International Trials Organisation. Definition and validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease activity score cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2021;73:1966–75.
pubmed: 34582120
pmcid: 8597164
doi: 10.1002/art.41879
World Health Organization. https://apps.who.int/iris/handle/10665/336656 . Accessed 25 Jun 2023.
Finger JD, Varnaccia G, Borrmann A, Lange C, Mensink GBM. Physical activity among children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends. J Health Monit. 2018;3:23–30.
pubmed: 35586180
pmcid: 8848914
Mullick MS, Nahar JS, Haq SA. Psychiatric morbidity, stressors, impact, and burden in juvenile idiopathic arthritis. J Health Popul Nutr. 2005;23:142–9.
pubmed: 16117366
Bomba M, Meini A, Molinaro A, Cattalini M, Oggiano S, Fazzi E, et al. Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. Rheumatol Int. 2013;33:2045–52.
pubmed: 23392772
doi: 10.1007/s00296-013-2685-4
Oommen PT, Klotsche J, Dressler F, Foeldvari I, Foell D, Horneff G, et al. Frequency of depressive and anxious symptoms in patients with juvenile idiopathic arthritis (JIA) – data from the Inception Cohort of newly diagnosed patients with JIA (ICON). Annals Rheumatic Dis. 2022;81:143.
doi: 10.1136/annrheumdis-2022-eular.3925
Sauer K, Barkmann C, Klasen F, Bullinger M, Glaeske G, Ravens-Sieberer U. How often do German children and adolescents show signs of common mental health problems? Results from different methodological approaches–a cross-sectional study. BMC Public Health. 2014;14:229.
pubmed: 24597565
pmcid: 3996039
doi: 10.1186/1471-2458-14-229
Ivarsson T, Gillberg C. Depressive symptoms in Swedish adolescents: normative data using the Birleson Depression Self-Rating Scale (DSRS). J Affect Disord. 1997;42:59–68.
pubmed: 9089059
doi: 10.1016/S0165-0327(96)00098-5
Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46:266–74.
pubmed: 18388841
doi: 10.1097/MLR.0b013e318160d093
Theuring S, Kern M, Hommes F, Mall MA, Seybold J, Mockenhaupt FP, et al. Generalized anxiety disorder in Berlin school children after the third COVID-19 wave in Germany: a cohort study between June and September 2021. Child Adolesc Psychiatry Ment Health. 2023;17:1.
pubmed: 36597131
pmcid: 9808730
doi: 10.1186/s13034-022-00552-0
Scheiner C, Grashoff J, Kleindienst N, Buerger A. Mental disorders at the beginning of adolescence: prevalence estimates in a sample aged 11–14 years. Public Health Pract (Oxf). 2022;4:100348.
pubmed: 36545674
doi: 10.1016/j.puhip.2022.100348
Koenig J, Kohls E, Moessner M, Lustig S, Bauer S, Becker K, et al. The impact of COVID-19 related lockdown measures on self-reported psychopathology and health-related quality of life in German adolescents. Eur Child Adolesc Psychiatry. 2023;32:113–22.
pubmed: 34247297
doi: 10.1007/s00787-021-01843-1
Ravens-Sieberer U, Kaman A, Erhart M, Devine J, Schlack R, Otto C. Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany. Eur Child Adolesc Psychiatry. 2022;31:879–89.
pubmed: 33492480
doi: 10.1007/s00787-021-01726-5
Milatz F, Albrecht A, Minden K, Marschall U, Klotsche J, Callhoff J. Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data. Pediatr Rheumatol Online J. 2024;22:10.
pubmed: 38183044
pmcid: 10768083
doi: 10.1186/s12969-023-00948-y
Kim S, Lee HK, Lee K, Which. PHQ-9 items can effectively screen for suicide? Machine learning approaches. Int J Environ Res Public Health. 2021;18:3339.
pubmed: 33804879
pmcid: 8036742
doi: 10.3390/ijerph18073339
Horowitz LM, Mournet AM, Lanzillo E, He JP, Powell DS, Ross AM, et al. Screening Pediatric Medical patients for suicide risk: is Depression Screening Enough? J Adolesc Health. 2021;68:1183–88.
pubmed: 33712380
pmcid: 8154669
doi: 10.1016/j.jadohealth.2021.01.028
Horowitz LM, Bridge JA, Tipton MV, Abernathy T, Mournet AM, Snyder DJ, et al. Implementing suicide risk screening in a Pediatric Primary Care setting: from research to practice. Acad Pediatr. 2022;22:217–26.
pubmed: 35248306
pmcid: 8908796
doi: 10.1016/j.acap.2021.10.012
Hughes JL, Horowitz LM, Ackerman JP, Adrian MC, Campo JV, Bridge JA. Suicide in young people: screening, risk assessment, and intervention. BMJ. 2023;381:e070630.
pubmed: 37094838
doi: 10.1136/bmj-2022-070630
Kyllönen MS, Ebeling H, Kautiainen H, Puolakka K, Vähäsalo P. Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study. Pediatr Rheumatol Online J. 2021;19:105.
pubmed: 34215280
pmcid: 8252279
doi: 10.1186/s12969-021-00599-x
El-Najjar AR, Negm MG, El-Sayed WM. The relationship between depression, disease activity and physical function in juvenile idiopathic arthritis patients in Zagazig University Hospitals - Egypt. Egypt Rheumatologist. 2014;36:145–50.
doi: 10.1016/j.ejr.2014.01.001
Butler A, Van Lieshout RJ, Lipman EL, MacMillan HL, Gonzales A, Gorter JW, et al. Mental disorder in children with physical conditions: a pilot study. BMJ Open. 2018;8:e019011.
pubmed: 29301763
pmcid: 5781020
doi: 10.1136/bmjopen-2017-019011
Vuorimaa H, Tamm K, Honkanen V, Konttinen YT, Komulainen E, Santavirta N. Empirical classification of children with JIA: a multidimensional approach to pain and well-being. Clin Exp Rheumatol. 2008;26:954–61.
pubmed: 19032837
Roemer J, Klein A, Horneff G. Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis. Rheumatol Int. 2023;43:1497–505.
pubmed: 37039854
pmcid: 10261240
doi: 10.1007/s00296-023-05323-4
Patil P, Parker RA, Rawcliffe C, Olaleye A, Moore S, Daly N, et al. Methotrexate induced nausea and vomiting in adolescent and young adult patients. Clin Rheumatol. 2014;33:403–7.
pubmed: 24108504
doi: 10.1007/s10067-013-2389-x
Galvez-Sánchez CM, Montoro CI, Duschek S, Reyes Del Paso GA. Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia. J Affect Disord. 2020;265:486–95.
pubmed: 32090776
doi: 10.1016/j.jad.2020.01.129
Guddal MH, Stensland SØ, Småstuen MC, Johnsen MB, Zwart JA, Storheim K. Physical activity and sport participation among adolescents: associations with mental health in different age groups. Results from the Young-HUNT study: a cross-sectional survey. BMJ open. 2019;9: e028555.
Hyrich KL, Lal SD, Foster HE, Thornton J, Adib N, Baildam E, et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis prospective study. Rheumatology (Oxford). 2010;49:116–22.
pubmed: 19926670
doi: 10.1093/rheumatology/kep352